亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Method of Extracting Neural Stem Cells Using Nanoparticles

總結
This invention relates to a method of extracting biological cells from a subject, particularly, but not exclusively, a method of extracting neural stem cells from a living subject.
技術優勢
Safely extracting neural stem cells from a living subject
技術應用
This technology though in an early stage of development, may give exciting potentials in biological and clinical applications, particularly in the area of regenerative medicinal treatment, from bench to bed.
詳細技術說明
A method of extracting neural stem cells from a living subject, comprising the steps of introducing magnetic nanoparticles into the subject, targeting the neural stem cells with the magnetic nanoparticles to form magnetic nanoparticle-targeted cells, isolating the magnetic nanoparticle-targeted cells, extracting the magnetic nanoparticles-targeted cells from the subject.
附加資料
Inventor: CHEAH, Songeng, Kathryn | ZHANG, Linchyngjian, Janet
Priority Number: WO2006010323A1
IPC Current: C12N000500
Assignee Applicant: The University of Hong Kong
Title: PROCOLLAGEN IIA DEFICIENT MICE | SOURIS DEFICIENTE EN PROCOLAGENE IIA
Usefulness: PROCOLLAGEN IIA DEFICIENT MICE | SOURIS DEFICIENTE EN PROCOLAGENE IIA
Summary: (M1) is useful for producing mutant Col2A-1 transgenic mouse. (M2) is useful for producing a mutant mouse. (I) is useful for screening agents for treatment of a selected cardiac disorder, where the selected cardiac disorders include sudden cardiac death, cardiomegaly, cardiomyocyte, hypertrophy, cellular disarray, pulmonary hypertension with right ventricular hypertrophy, and valvular fibrosis (all claimed). (M1) is useful for screening potential drugs against ventricular remodeling, malignant arrhythmias, and congenital heart disease.
Novelty: Producing mutant procollagen IIA (Col2A-1) transgenic mouse, by introducing selected mouse embryonic stem cells having mutant Col2A-1 transgene into mouse blastocysts, and crossing chimeric founder transgenic mouse with wild-type mouse
申請日期
2013.03.15
申請號碼
US 13/834,750
其他
Filed
ID號碼
A61/YK/Vivo/US01
國家/地區
香港

欲了解更多信息,請點擊 這裡
移動設備